Point of Care Testing – Global Analysis & Market Forecasts

June 2016 | 82 pages | ID: PE115D2FDB9EN
DPI Research

Abstracts

Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field.

The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and technological advancements with regard to development of advanced, faster, and easy to–use devices are stimulating the demand for POCT

This report titled “Point of Care Testing – Global Analysis & Market Forecasts” provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals and collaboration deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.

The following 13 segments of the point of care testing market are detailed with market size and six year forecast.

• Blood Glucose Testing
• Cardiac Markers Testing
• Lipid Panel/Cholesterol Testing
• Blood Coagulation Testing
• Infectious Disease Testing
• Urinalysis Testing
• Drug of Abuse Testing
• Pregnancy & Fertility Testing
• Cancer Markers Testing
• Critical Care Testing
• HbA1C Testing
• Clinical Chemistry Testing
• Bilirubin Testing

This report also gives access to significant data such as:

• Market Growth Drivers in the Point of Care Testing Market
• Challenges in the Point of Care Testing Market
• Current Market Trends
• Market Forecasting for the Coming Years
• Merger & Acquisitions between major companies
• Distribution Agreement
• Licensing Deals
• Collaboration Deals

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL – POINT OF CARE TESTING MARKET & FORECAST (2010 – 2022)

3. GLOBAL – POINT OF CARE TESTING MARKET SHARE & FORECAST (2010 – 2022)

4. POINT OF CARE TESTING MARKET – TESTING SEGMENT ANALYSIS

4.1 Blood Glucose Testing Market & Forecast
4.2 Blood Coagulation Testing Market & Forecast
4.3 Infectious Disease Testing Market & Forecast
4.4 Clinical Chemistry Testing Market & Forecast
4.5 Cardiac Markers Testing Market & Forecast
4.6 Pregnancy & Fertility Testing Market & Forecast
4.7 Urinalysis Testing Market & Forecast
4.8 Cancer Markers Testing Market & Forecast
4.9 Drugs of Abuse Testing Market & Forecast
4.10 Hemoglobin A1C (HbA1c) Testing Market & Forecast
4.11 Lipid Panel/Cholesterol Testing Market & Forecast
4.12 Critical Care Testing Market & Forecast
4.13 Bilirubin Testing Market & Forecast

5. POINT OF CARE TESTING MARKET – MAJOR DEALS TYPE

5.1 Merger & Acquisition in Point of Care Testing Market
5.2 Distribution Agreement in Point of Care Testing Market
5.3 Licensing Deals in Point of Care Testing Market
5.4 Collaboration Deals in Point of Care Testing Market

6. POINT OF CARE TESTING MARKET – GROWTH DRIVERS

6.1 Healthcare Reform – Patient–Centered Care
6.2 Recent Development & Demand of Self Testing Drive the Point of Care Testing Market
6.3 Industry Has Been Witnessing Significant Technological Advancements Over the Last Five Years
6.4 Advancement of Self Testing to Mark Significant Progress In The Coming Years

7. POINT OF CARE TESTING MARKET – CHALLENGES

7.1 Hindrances in Point of Care Diagnostics Test Development
7.2 Costlier POC Testing Over Central Lab Methods – A Setback for the Market Growth
7.3 Reluctance Towards Adoption & Scale–up of POC Technologies in Many Parts of the World to Hinder the Market Growth

List Of Tables

LIST OF TABLES

Table 3–1: Global – Point of Care Testing Market Share (Percent), 2010 – 2015
Table 3–2: Global – Forecast for Point of Care Testing Market Share (Percent), 2016 – 2022
Table 5–1: Global – Merger & Acquisition in Point of Care Testing Market, 2006 – 2016
Table 5–2: Distribution Agreement in Point of Care Testing Market, 2008 – 2016
Table 5–3: Licensing Deals in Point of Care Testing Market, 2008 – 2016
Table 5–4: Collaboration Deals in Point of Care Testing Market, 2013 – 2016
Table 7–1: Cost Comparisons between POCT & Central Laboratory Testing (US$), 2009
Table 7–2: Hypothetical Labor Steps Involved in Central Laboratory Testing V/S POCT
Table 7–3: Barriers to Adoption & Scale–up of POC Technologies
Table 7–4: Technical, Administrative & Operational Barriers of POC Tests in Low & Middle Income Countries
Table 7–5: Health System Related Barriers of POC Tests in Low & Middle Income Countries
Table 7–6: Economic Barriers of POC Tests in Low & Middle Income Countries

List Of Figures

LIST OF FIGURES

Figure 2–1: Global – Point of Care Testing Market (Million US$), 2010 – 2015
Figure 2–2: Global – Forecast for Point of Care Testing Market (Million US$), 2016 – 2022
Figure 4–1: Global – Blood Glucose Testing Market (Million US$), 2010 – 2015
Figure 4–2: Global – Forecast for Blood Glucose Testing Market (Million US$), 2016 – 2022
Figure 4–3: Global – Blood Coagulation Market (Million US$), 2008 – 2015
Figure 4–4: Global – Forecast for Blood Coagulation Market (Million US$), 2016 – 2022
Figure 4–5: Global – Infectious Disease Testing Market (Million US$), 2008 – 2015
Figure 4–6: Global – Forecast for Infectious Disease Testing Market (Million US$), 2016 – 2022
Figure 4–7: Global – Clinical Chemistry Testing Market (Million US$), 2008 – 2015
Figure 4–8: Global – Forecast for Clinical Chemistry Testing Market (Million US$), 2016 – 2022
Figure 4–9: Global – Cardiac Markers Testing Market (Million US$), 2008 – 2015
Figure 4–10: Global – Forecast for Cardiac Markers Testing Market (Million US$), 2016 – 2022
Figure 4–11: Global – Pregnancy & Fertility Testing Market (Million US$), 2008 – 2015
Figure 4–12: Global – Forecast for Pregnancy & Fertility Testing Market (Million US$), 2016 – 2022
Figure 4–13: Global – Urinalysis Testing Market (Million US$), 2008 – 2015
Figure 4–14: Global – Forecast for Urinalysis Testing Market (Million US$), 2016 – 2022
Figure 4–15: Global – Cancer Markers Testing Market (Million US$), 2008 – 2015
Figure 4–16: Global – Forecast for Cancer Markers Testing Market (Million US$), 2016 – 2022
Figure 4–17: Global – Drug of Abuse Testing Market (Million US$), 2007 – 2015
Figure 4–18: Global – Forecast for Drug of Abuse Testing Market (Million US$), 2016 – 2022
Figure 4–19: Global – HbA1c Testing Market (Million US$), 2008 – 2015
Figure 4–20: Global – Forecast for HbA1c Testing Market (Million US$), 2016 – 2022
Figure 4–21: Global – Lipid Panel/Cholesterol Testing Market (Million US$), 2008 – 2015
Figure 4–22: Global – Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2016 – 2022
Figure 4–23: Global – Critical Care Testing Market (Million US$), 2008 – 2015
Figure 4–24: Global – Forecast for Critical Care Testing Market (Million US$), 2016 – 2022
Figure 4–25: Global – Bilirubin Testing Market (Million US$), 2007 – 2015
Figure 4–26: Global – Forecast for Bilirubin Testing Market (Million US$), 2016 – 2022